4//SEC Filing
Keswani Sanjay Chandru 4
Accession 0000914475-25-000146
CIK 0000914475other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 5:37 PM ET
Size
7.9 KB
Accession
0000914475-25-000146
Insider Transaction Report
Form 4
Keswani Sanjay Chandru
Chief Medical Officer
Transactions
- Award
Stock Option
2025-06-02+70,101→ 70,101 totalExercise: $124.56Exp: 2035-06-02→ Common Stock (70,101 underlying) - Award
Restricted Stock Unit
2025-06-02+12,846→ 12,846 totalExercise: $0.00→ Common Stock (12,846 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's Common Stock upon vesting.
- [F2]The Restricted Stock Units will vest annually at 25% of the units vesting on each of June 2, 2026, June 2, 2027, June 2, 2028, and June 2, 2029.
- [F3]Represents option of which 1/4th of the shares underlying the option becomes vested and exercisable on June 2, 2026 and an additional 1/48th of the shares underlying the option becomes vested and excercisable each month thereafter.
Documents
Issuer
NEUROCRINE BIOSCIENCES INC
CIK 0000914475
Entity typeother
Related Parties
1- filerCIK 0001818524
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 5:37 PM ET
- Size
- 7.9 KB